Aluminium intoxication in renal disease.

Area of Science:

• Nephrology
• Toxicology
• Neurology

Background:

• Aluminium intoxication in renal failure presents in acute (weeks/months) and chronic (years) forms.
• Sources include contaminated dialysis fluids, parenteral solutions, and oral phosphate binders.
• Intoxication affects multiple organ systems, including the brain, bones, parathyroid glands, heart, and lymphocytes.

Purpose of the Study:

• To review evidence on the long-term effects of low-level aluminium overload in renal failure.
• To investigate potential gradual cerebral function deterioration.
• To determine if this deterioration resembles Alzheimer's disease or dialysis encephalopathy.

Main Methods:

• Review of existing literature and clinical evidence on aluminium toxicity in renal failure patients.
• Analysis of symptoms and progression in cases of subacute and slow aluminium poisoning.
• Comparison of neurological and systemic manifestations.

Main Results:

• Aluminium intoxication can manifest as encephalopathy, bone disease, parathyroid suppression, anemia, and potential cardiac/lymphocyte damage.
• Slow aluminium poisoning primarily affects bones but can co-occur with encephalopathy.
• Evidence suggests low-level aluminium overload in renal failure patients causes gradual cerebral function decline.

Conclusions:

• Low-level aluminium overload in renal failure likely leads to progressive cerebral dysfunction.
• This cognitive decline may resemble a slow-onset form of dialysis encephalopathy rather than Alzheimer's disease.